Project overview
The Life After Prostate Cancer Diagnosis (LAPCD) study is a UK-wide patient-reported outcomes study designed to generate information to improve the health and well-being of men with prostate cancer. Postal surveys will be sent to prostate cancer survivors (18–42 months postdiagnosis) in all 4 UK countries (n=∼70 000), and qualitative interviews will be undertaken with a sample of men who complete the survey across the UK (n=∼150) along with a small number of partners/spouses (n=∼30)
Staff
Lead researcher
Research outputs
Lauren Matheson, Johana Nayoan, Carol Rivas, Jo Brett, Penny Wright, Hugh Butcher, Anna Gavin, Adam Glaser, Eila Watson & Richard Wagland,
2020, Oncology Nursing Forum, 47(3), 318-330
Type: article
Sarah Wilding, Amy Downing, Peter Selby, William Cross, Penny Wright, Eila K. Watson, Richard Wagland, Paul Kind, David W. Donnelly, Luke Hounsome, Rebecca Mottram, Majorie Allen, Therese Kearney, Hugh Butcher, Anna Gavin & Adam Glaser,
2020, Psycho-Oncology, 29(5), 886-893
DOI: 10.1002/pon.5362
Type: article
Lauren Mattheson, Johana Nayoan, Carol Rivas, Jo Brett, Penny Wright, Hugh Butcher, Anna Gavin, Adam Glaser, Eila Watson & Richard Wagland,
2019, Oncology Nursing Forum
Type: article
Richard Wagland, Johana Nayoan, Lauren Matheson, Carol Rivas, Jo Brett, Nicole Collaço, Obrey Alexis, Gavin Anna, Adam W. Glaser & Eila Watson,
2019, European Journal of Cancer Care
DOI: 10.1111/ecc.13183
Type: article
David W Donnelly, Linda C Vis, Therese Kearney, Linda Sharp, Damien Bennett, Sarah Wilding, Amy Downing, Penny Wright, Eila Watson, Richard Wagland, William R Cross, Malcolm D Mason, Sabine Siesling, Jeannette G van Manen, Adam W Glaser & Anna Gavin Gavin,
2019, BMC cancer, 19
Type: article